1. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. (2006): Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. Am J Psychiatry 163:1905–1917.
2. Pizzagalli DA, Roberts AC (2022): Prefrontal cortex and depression [published correction appears in Neuropsychopharmacology 2022; 47: 609]. Neuropsychopharmacology 47:225–246.
3. Ploski JE, Vaidya VA (2021): The neurocircuitry of posttraumatic stress disorder and major depression: Insights into overlapping and distinct circuit dysfunction-A tribute to Ron Duman. Biol Psychiatry 90:109– 117.
4. Krishnan V, Nestler EJ (2010): Linking molecules to mood: New insight into the biology of depression. Am J Psychiatry 167:1305–1320.
5. Drevets WC (2000): Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res 126:413–431.
6. Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, et al. (1999): Reciprocal limbic-cortical function and negative mood: Converging PET findings in depression and normal sadness. Am J Psychiatry 156:675–682.
7. Duman RS, Aghajanian GK (2012): Synaptic dysfunction in depression: Potential therapeutic targets. Science 338:68–72.
8. Girgenti MJ, Wang J, Ji D, Cruz DA, Traumatic Stress Brain Research Group, Stein MB, et al. (2021): Transcriptomic organization of the human brain in post-traumatic stress disorder. Nat Neurosci 24:24–33.
9. Sequeira A, Mamdani F, Ernst C, Vawter MP, Bunney WE, Lebel V, et al. (2009): Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One 4:e6585.
10. Nagy C, Maitra M, Tanti A, Suderman M, Théroux JF, Davoli MA, et al. (2020): Single-nucleus transcriptomics of the prefrontal cortex in major depressive disorder implicates oligodendrocyte precursor cells and excitatory neurons. Nat Neurosci 23:771–781.
11. Duman RS, Sanacora G, Krystal JH (2019): Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron 102:75–90.
12. Covington HE 3rd, Lobo MK, Maze I, Vialou V, Hyman JM, Zaman S, et al. (2010): Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex. J Neurosci 30:16082–16090.
13. Moda-Sava RN, Murdock MH, Parekh PK, Fetcho RN, Huang BS, Huynh TN, et al. (2019): Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation. Science 364: eaat8078.
14. Ferenczi EA, Zalocusky KA, Liston C, Grosenick L, Warden MR, Amatya D, et al. (2016): Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior. Science 351:aac9698.
15. Uchida S, Hara K, Kobayashi A, Funato H, Hobara T, Otsuki K, et al. (2010): Early life stress enhances behavioral vulnerability to stress through the activation of REST4-mediated gene transcription in the medial prefrontal cortex of rodents. J Neurosci 30:15007–15018.
16. Bagot RC, Cates HM, Purushothaman I, Vialou V, Heller EA, Yieh L, et al. (2017): Ketamine and imipramine reverse transcriptional signatures of susceptibility and induce resilience-specific gene expression profiles. Biol Psychiatry 81:285–295.
17. Dulawa SC, Holick KA, Gundersen B, Hen R (2004): Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29:1321–1330.
18. Schmidt EF, Warner-Schmidt JL, Otopalik BG, Pickett SB, Greengard P, Heintz N (2012): Identification of the cortical neurons that mediate antidepressant responses. Cell 149:1152–1163.
19. Crowley JJ, Brodkin ES, Blendy JA, Berrettini WH, Lucki I (2006): Pharmacogenomic evaluation of the antidepressant citalopram in the mouse tail suspension test. Neuropsychopharmacology 31:2433– 2442.
20. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al. (2003): Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805–809.
21. Uchida S, Hara K, Kobayashi A, Otsuki K, Yamagata H, Hobara T, et al. (2011): Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron 69:359– 372.
22. Golden SA, Covington HE 3rd, Berton O, Russo SJ (2011): A standardized protocol for repeated social defeat stress in mice [published correction appears in Nat Protoc 2015; 10:643]. Nat Protoc 6:1183–1191.
23. Sakai Y, Li H, Inaba H, Funayama Y, Ishimori E, Kawatake-Kuno A, et al. (2021): Gene-environment interactions mediate stress susceptibility and resilience through the CaMKIIb/TARPg-8/AMPAR pathway. iScience
24:102504. 24. Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ, et al. (2007): Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131:391–404.
25. Uchida S, Hara K, Kobayashi A, Fujimoto M, Otsuki K, Yamagata H, et al. (2011): Impaired hippocampal spinogenesis and neurogenesis and altered affective behavior in mice lacking heat shock factor 1. Proc Natl Acad Sci U S A 108:1681–1686.
26. Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, et al. (2016): NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533:481–486.
27. Casarotto PC, Girych M, Fred SM, Kovaleva V, Moliner R, Enkavi G, et al. (2021): Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell 184:1299–1313.e19.
28. Porsolt RD, Le Pichon M, Jalfre M (1977): Depression: A new animal model sensitive to antidepressant treatments. Nature 266:730–732.
29. David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I, et al. (2009): Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62:479– 493.
30. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. (2006): Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. Am J Psychiatry 163:28–40.
31. Laine MA, Trontti K, Misiewicz Z, Sokolowska E, Kulesskaya N, Heikkinen A, et al. (2018): Genetic control of myelin plasticity after chronic psychosocial stress. eNeuro 5: ENEURO.0166-18.2018.
32. Luo Y, Kataoka Y, Ostinelli EG, Cipriani A, Furukawa TA (2020): National prescription patterns of antidepressants in the treatment of adults with major depression in the US between 1996 and 2015: A population representative survey based analysis [published correction appears in Front Psychiatry 2020; 11:171]. Front Psychiatry 11:35.
33. Yu Z, Zhang J, Zheng Y, Yu L (2020): Trends in antidepressant use and expenditure in six major cities in China from 2013 to 2018. Front Psychiatry 11:551.
34. Doyle JP, Dougherty JD, Heiman M, Schmidt EF, Stevens TR, Ma G, et al. (2008): Application of a translational profiling approach for the comparative analysis of CNS cell types [published correction appears in Cell 2009; 139:1022]. Cell 135:749–1762.
35. Heiman M, Schaefer A, Gong S, Peterson JD, Day M, Ramsey KE, et al. (2008): A translational profiling approach for the molecular characterization of CNS cell types. Cell 135:738–748.
36. Carrillo-Roa T, Labermaier C, Weber P, Herzog DP, Lareau C, Santarelli S, et al. (2017): Common genes associated with antidepressant response in mouse and man identify key role of glucocorticoid receptor sensitivity. PLoS Biol 15:e2002690.
37. Sittig LJ, Carbonetto P, Engel KA, Krauss KS, Barrios-Camacho CM, Palmer AA (2016): Genetic background limits generalizability of genotype-phenotype relationships. Neuron 91:1253–1259.
38. Rogge G, Jones D, Hubert GW, Lin Y, Kuhar MJ (2008): CART peptides: Regulators of body weight, reward and other functions [published correction appears in Nat Rev Neurosci 2010; 11:218]. Nat Rev Neurosci 9:747–758.
39. Lau J, Herzog H (2014): CART in the regulation of appetite and energy homeostasis. Front Neurosci 8:313.
40. Singh A, de Araujo AM, Krieger JP, Vergara M, Ip CK, de Lartigue G (2021): Demystifying functional role of cocaine- and amphetaminerelated transcript (CART) peptide in control of energy homeostasis: A twenty-five year expedition. Peptides 140:170534.
41. Ahmadian-Moghadam H, Sadat-Shirazi MS, Zarrindast MR (2018): Cocaine- and amphetamine-regulated transcript (CART): A multifaceted neuropeptide. Peptides 110:56–77.
42. Yanik T, Dominguez G, Kuhar MJ, Del Giudice EM, Loh YP (2006): The Leu34Phe ProCART mutation leads to cocaine- and amphetamineregulated transcript (CART) deficiency: A possible cause for obesity in humans. Endocrinology 147:39–43.
43. Miraglia del Giudice E, Santoro N, Fiumani P, Dominguez G, Kuhar MJ, Perrone L (2006): Adolescents carrying a missense mutation in the CART gene exhibit increased anxiety and depression. Depress Anxiety 23:90–92.
44. Orsetti M, Di Brisco F, Canonico PL, Genazzani AA, Ghi P (2008): Gene regulation in the frontal cortex of rats exposed to the chronic mild stress paradigm, an animal model of human depression. Eur J Neurosci 27:2156–2164.
45. Roh MS, Cui FJ, Ahn YM, Kang UG (2009): Up-regulation of cocaineand amphetamine-regulated transcript (CART) in the rat nucleus accumbens after repeated electroconvulsive shock. Neurosci Res 65:210–213.
46. van Heukelum S, Mars RB, Guthrie M, Buitelaar JK, Beckmann CF, Tiesinga PHE, et al. (2020): Where is cingulate cortex? A cross-species view. Trends Neurosci 43:285–299.
47. Bicks LK, Koike H, Akbarian S, Morishita H (2015): Prefrontal cortex and social cognition in mouse and man. Front Psychol 6:1805.
48. Vogt BA, Paxinos G (2014): Cytoarchitecture of mouse and rat cingulate cortex with human homologies. Brain Struct Funct 219:185–192.
49. Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, Mayberg H (2004): Modulation of cortical-limbic pathways in major depression: Treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 61:34–41.
50. Goodman M, Hazlett EA, Avedon JB, Siever DR, Chu KW, New AS (2011): Anterior cingulate volume reduction in adolescents with borderline personality disorder and co-morbid major depression. J Psychiatr Res 45:803–807.
51. Youssef MM, Underwood MD, Huang YY, Hsiung SC, Liu Y, Simpson NR, et al. (2018): Association of BDNF Val66Met polymorphism and brain BDNF levels with major depression and suicide. Int J Neuropsychopharmacol 21:528–538.
52. Gibbons A, McPherson K, Gogos A, Dean B (2021): An investigation into nicotinic receptor involvement in mood disorders uncovers novel depression candidate genes. J Affect Disord 288:154–160.
53. Shao LX, Liao C, Gregg I, Davoudian PA, Savalia NK, Delagarza K, Kwan AC (2021): Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. Neuron 109:2535–2544.e4.
54. Northoff G, Sibille E (2014): Why are cortical GABA neurons relevant to internal focus in depression? A cross-level model linking cellular, biochemical and neural network findings. Mol Psychiatry 19:966–977.
55. Sanacora G, Mason GF, Rothman DL, Krystal JH (2002): Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 159:663–665.
56. Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB, et al. (2003): Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 160:577–579.
57. Dubin MJ, Mao X, Banerjee S, Goodman Z, Lapidus KAB, Kang G, et al. (2016): Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy. J Psychiatry Neurosci 41:E37– E45.
58. Milak MS, Proper CJ, Mulhern ST, Parter AL, Kegeles LS, Ogden RT, et al. (2016): A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder. Mol Psychiatry 21:320–327.
59. Fogaça MV, Wu M, Li C, Li XY, Picciotto MR, Duman RS (2021): Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses. Mol Psychiatry 26:3277–3291.
60. Fuchs T, Jefferson SJ, Hooper A, Yee PH, Maguire J, Luscher B (2017): Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state. Mol Psychiatry 22:920–930.
61. Perova Z, Delevich K, Li B (2015): Depression of excitatory synapses onto parvalbumin interneurons in the medial prefrontal cortex in susceptibility to stress. J Neurosci 35:3201–3206.
62. Labonté B, Engmann O, Purushothaman I, Menard C, Wang J, Tan C, et al. (2017): Sex-specific transcriptional signatures in human depression [published correction appears in Nat Med 2018; 24:525]. Nat Med 23:1102–1111.
63. Kawatake-Kuno A, Murai T, Uchida S (2021): The molecular basis of depression: Implications of sex-related differences in epigenetic regulation. Front Mol Neurosci 14:708004.
64. Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, et al. (2000): Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 157:1445–1452.
65. Uhr M, Tontsch A, Namendorf C, Ripke S, Lucae S, Ising M, et al. (2008): Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression. Neuron 57:203– 209.
66. Foster SR, Hauser AS, Vedel L, Strachan RT, Huang XP, Gavin AC, et al. (2019): Discovery of human signaling systems: Pairing peptides to G protein-coupled receptors. Cell 179:895–908.e21.
67. Yosten GL, Harada CM, Haddock C, Giancotti LA, Kolar GR, Patel R, et al. (2020): GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents. J Clin Invest 130:2587–2592.
論文の公開元へ
